Back
3D Systems Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
26
DDD
3D Systems
Last Price:
3.07
Seasonality Move:
-5.95%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
26
3D Systems (DDD)
is a Sell
Is 3D Systems a Buy, Sell or Hold?
- The current 3D Systems [DDD] share price is $3.07. The Score for DDD is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- DDD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DDD Stock Price Chart
What is 3D Systems's stock price today?
-
The 3D Systems share price today is $3.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DDD is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
DDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 33.88 | Sell |
Chaikin Money Flow: | -446782 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.3 - 3.94) | Sell |
Bollinger Bands (100): | (3.46 - 4.7) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.83 | Buy |
Relative Strength Index (14 RSI): | 90.67 | Buy |
Chaikin Money Flow: | -365678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.21 - 198.95) | Buy |
Bollinger Bands (100): | (137.63 - 173.99) | Buy |
DDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.35 | Sell |
20-day SMA: | 3.64 | Sell |
50-day SMA: | 3.61 | Sell |
200-day SMA: | 4.53 | Sell |
8-day EMA: | 3.32 | Sell |
20-day EMA: | 3.52 | Sell |
50-day EMA: | 3.71 | Sell |
200-day EMA: | 4.91 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 198.72 | Buy |
20-day SMA: | 171.59 | Buy |
50-day SMA: | 157.67 | Buy |
200-day SMA: | 165.81 | Buy |
8-day EMA: | 210.85 | Buy |
20-day EMA: | 183.04 | Buy |
50-day EMA: | 165.87 | Buy |
200-day EMA: | 167.34 | Buy |
3D Systems Earnings Growth & DDD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.03 per share, and an increase next year of $0.13 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
3D Systems Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |